MEDICAL JOURNAL ARTICLES

ARTICLES FOR: TOXICOLOGY FARTHER BELOW

PHARMACOGENETICS

CLINICAL APPLICATION OF CARDIOVASCULAR PGx (2016)

PGx & CARDIOVASCULAR DISEASE (July 2013)

PGx TESTING: TIME FOR CLINICAL PRACTICE GUIDELINES (Nov 2010)

EFFECTS OF CYP2C19 GENOTYPE ON OUTCOMES OF CLOPIDOGREL TREATMENT (2010)

IMPLEMENTING PGx INTO MEDICAL MANAGEMENT (September 2016)

MAYO PSYCHIATRIC PRECISION MEDICINE (July 2016)

PGx AUSTRIAN STUDY (2016)

PGx FOR TREATMENT OF ADHD (2013)

PGx TESTING IN CHILDREN (June 2016)

9 QUESTIONS ABOUT PRECISION MEDICINE, ANSWERED (March 2016)

AACC URGES DEVELOPMENT OF AND COVERAGE FOR INNOVATIVE PERSONALIZED MEDICINE LAB TEST (June 2015)

AMERICAN HOLOCAUST - ADVERSE DRUG REACTION (January 2014)

PHARMACOGENETICS: USING DNA TO OPTIMIZE DRUG THERAPY (October 2007)

IS YOUR MEDICINE RIGHT FOR YOUR METABOLISM?  (March 2016)

CPIC GUIDELINES FOR PHARMACOGENETICS

CYP2D6 METABOLISM PREDICTS OPIOID RESPONSE (June 2007)

POTENTIAL DRUG INTERACTIONS ARE COMMON FOR HOSPITALIZED KIDS (January 2015)

FDA TABLE OF PHARMACOGENOMIC BIOMARKERS IN DRUG LABELING

PHARMACOGENETIC TESTING: TIME FOR CLINICAL PRACTICE GUIDELINES (June 2011)

PHYSICIAN LIABILITY:  THE NEXT BIG THING FOR PERSONALIZED MEDICINE?  (August 2011)

AMA PHARMACOGENOMICS: INCREASING THE SAFETY AND EFFECTIVENESS OF DRUG THERAPY (2011)

PHARMACISTS CALLED TO TAKE LEAD IN PHARMACOGENOMICS (November 2015)

PERSONALIZED PAIN MEDICINE: PHARMACOGENETIC TESTING FOR PAIN AND OPIOID ADDICTION (September 2015)

PHARMACOGENETIC TESTING IN PAIN MEDICINE: EXPERTS WEIGH IN (December 2014)

PSYCHIATRIC PHARMACOGENOMICS PREDICTS HEALTH RESOURCE UTILIZATION OF OUTPATIENTS WITH ANXIETY AND DEPRESSION (November 2012)

ACOG - NATIONAL INSTITUTE OF HEALTH - CANCER.NET - MERCK - WHY ESTABLISH PHARMACOGENETICS IN YOUR CLINIC